Polyrizon Ltd.PLRZ

$13.42+0.19 (+1.44%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$22M

Micro-cap

-21%

2024 — today

10-Year Price

-99%

2024 — today

52-Week Range

$3.13$17.17

Current $13.42· 73%

Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.

Valuation in context

P/E ratio

-0.3

N/A

Not meaningful — company is unprofitable

P/B ratio

1.0

Around average

Around the 10-year average

FCF Yield

-16.3%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when PLRZ is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.